Key result
Drug-coated balloon venoplasty yields 100% success and durable patency in severe pulmonary vein stenosis.
Why the study?
Balloon angioplasty and stenting for pulmonary vein stenosis are limited by high rates of restenosis.
Does drug-coated balloon venoplasty improve symptoms and maintain vessel patency in patients with iatrogenic pulmonary vein stenosis?
Case Report (n=4)
Does drug-coated balloon venoplasty improve symptoms and maintain vessel patency in patients with iatrogenic pulmonary vein stenosis?
Drug-coated balloon venoplasty may offer a promising, low-restenosis alternative to standard angioplasty or stenting for severe iatrogenic pulmonary vein stenosis.
Hypothesis-generating for drug-coated balloon venoplasty in pulmonary vein stenosis; prospective trials needed before clinical adoption.
Pulmonary vein stenosis (PVS) is a condition that has seen a decrease in incidence in recent years. Whereas balloon angioplasty and stenting are both acceptable treatment options for PVS, they are limited by the high rate of restenosis. This research paper presents 4 cases of severe symptomatic PVS that were successfully treated with the use of drug-coated balloons, resulting in positive outcomes. (Level of Difficulty: Advanced.)
No takes yet. Share an insight, caveat, or question.
Salih et al. (2023) conducted a case report in Iatrogenic pulmonary vein stenosis (n=4). Drug-coated balloon venoplasty was evaluated on Symptom resolution and absence of restenosis. Drug-coated balloon venoplasty successfully treated severe symptomatic pulmonary vein stenosis in 4 patients, resulting in 100% procedural success, symptom resolution, and no restenosis at an average follow-up of 3.5 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from JACC Case Reports